IL-6 and other biomarkers as predictors of severity in COVID-19 (original) (raw)
Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: Potential immune-inflammatory parameters to identify severe and fatal forms of COVID-19
Mourad Ouali
Cytokine, 2021
View PDFchevron_right
Inflammation Associated with Disease Severity and Fatality of COVID-19
Saliha Chellak
Saudi Journal of Biomedical Research, 2021
View PDFchevron_right
Follow-up of Interleukin 6 and Other Blood Markers during the Hospitalization of COVID-19 Patients: A Single-Center Study
Diana Klajn
COVID
View PDFchevron_right
Interleukin-6 as a Potential Predictor of COVID-19 Disease Severity in Hospitalized Patients and its Association With Clinical Laboratory Routine Tests
Seyed Reza Raeeskarami
2020
View PDFchevron_right
Association between Inflammatory Markers and the Outcome of Critically Ill COVID-19 Patients
shafatuj jahan
Scholars journal of applied medical sciences, 2022
View PDFchevron_right
Correlation of inflammatory biomarkers with disease severity in hospitalised patients of COVID-19 at presentation
Hijab Batool
Journal of Fatima Jinnah Medical University
View PDFchevron_right
Interleukine-6 in critically ill COVID-19 patients: A retrospective analysis
Francis Corazza
PLOS ONE, 2020
View PDFchevron_right
Interleukin-6 role in the severity of COVID-19 and intensive care unit stay length
amir tabatabaei
Cellular and Molecular Biology, 2020
View PDFchevron_right
Interleukin-6 and C-reactive protein/albumin ratio as predictors of COVID-19 severity and mortality
ahmed alazzouni
The Egyptian Journal of Bronchology
View PDFchevron_right
Influence of IL-6 levels on patient survival in COVID-19
maicol concha
Journal of Critical Care, 2021
View PDFchevron_right
Serum Levels of Interleukin-6, Ferritin, C-Reactive Protein, Lactate Dehydrogenase, D-Dimer, and Count of Lymphocytes and Neutrophils in COVID-19 Patients: Its Correlation to the Disease Severity
Ali Saad Kadhim
2021
View PDFchevron_right
Inflammatory Biomarkers in COVID-19: Associations with Clinical Characteristics and Outcomes among COVID 19 Patients Hospitalized in Sukraraj Tropical and Infectious Disease Hospital
Kijan Maharjan
Journal of Advances in Internal Medicine, 2023
View PDFchevron_right
Could IL-6 predict the clinical severity of COVID-19?
hatice esen
Turkish Journal of Biochemistry
View PDFchevron_right
Association of Inflammatory Markers with Mortality in COVID-19 Infection
Abdul raheem Arshad
Journal of the College of Physicians and Surgeons Pakistan, 2020
View PDFchevron_right
Comparison of Inflammatory Markers with Different Levels of Severity of COVID-19 Disease
Numan Majeed
2020
View PDFchevron_right
Interleukin-6 and Its Soluble Receptor Complex in Intensive Care Unit COVID-19 Patients: An Analysis of Second Wave Patients
Valentina Rubino
Pathogens
View PDFchevron_right
Evaluating the levels of interleukin-6 and interleukin-10 as potential biomarkers for the severity and mortality in COVID-19 patients
Muslim Mohsin
International journal of health sciences
View PDFchevron_right
Association of inflammatory biomarker abnormalities with mortality in COVID-19: a meta-analysis
Arpita Suri
Bulletin of the National Research Centre, 2022
View PDFchevron_right
Elevated interleukin (IL)-6 as a predictor of disease severity among Covid-19 patients: a prospective cohort study
sabah hasani
BMC Infectious Diseases
View PDFchevron_right
Home Care Follow up determine the point of inversion of IL-6 levels in relation to C-Reactive Protein as the cytokine storm marker in COVID-19
Raul Honorato e Melo
2022
View PDFchevron_right
Relative Importance of Various Inflammatory Markers and Their Critical Thresholds for COVID-19 Mortality
mayur pawar
2021
View PDFchevron_right
Association of Inflammatory Markers with Disease Severity and Outcome in Covid-19 Patients
Zorica Nanovic, Aleksandra Gjuzelova
PRILOZI
View PDFchevron_right
Laboratory biomarkers associated with COVID-19 severity and management
Edmund Garr
View PDFchevron_right
High Levels of Circulating IL-6 and IL-8 Signature can Predict COVID-19 Severity
Onur Alkan
Jundishapur Journal of Microbiology, 2021
View PDFchevron_right
Evaluating the haematological and inflammatory markers in predicting the clinical outcome of COVID-19 patients admitted in a tertiary care hospital of Northern India
Roshni Agarwal
International Journal of Health Sciences (IJHS), 2022
View PDFchevron_right
Correlation of Interleukin 6 Levels with C-Reactive Protein in Various Severity of Covid-19 Patients in Rsup Dr. Mohammad Hoesin Palembang
Phey Liana
Journal of Medical and Health Studies
View PDFchevron_right
Investigating The Role of Inflammatory Markers at Admission in Defining the Severity of Moderate-to-Critical COVID-19: A Cross-Sectional Analysis
Imran Arshad
Journal of Community Hospital Internal Medicine Perspectives
View PDFchevron_right
Interleukin 6 and Its Correlation with COVID-19 in Terms of Outcomes in an Intensive Care Unit of a Rural Hospital:A Cross-sectional Study
sparsh madaan
Indian Journal of Critical Care Medicine
View PDFchevron_right
Assessment of inflammatory markers and their association with disease mortality in severe COVID-19 patients of tertiary care hospital in South India
Souparnika Sreelatha
The Egyptian Journal of Bronchology
View PDFchevron_right